Member Login

FDA approves gene-targeting melanoma drug

 

/uploadedImages/Advocacy/Advocacy_News/logo1c[1].gif  Nature reports that the Food and Drug Administration has approved Zelboraf, a first-of-its-kind drug that treats advanced melanomas by targeting the mutated B-RAF protein.   

 




Update on Appropriations 

ASBMB_blogs

Advocacy: Contact US